Gilead Sciences (GILD) Misses Q1 EPS by 5c; Reiterates Full Year 2017 Guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $127.88 --0%
EPS Growth %: -464.2%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
DTGI, OCCI, MAYS, More
EPS Growth %: -464.2%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $2.23, $0.05 worse than the analyst estimate of $2.28. Revenue for the quarter came in at $6.505 billion versus the consensus estimate of $6.62 billion.
Reiterates Full Year 2017 Guidance
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley continues to recommend exposure to the broadening theme
- Shake Shack (SHAK) Reiterated at Buy by DA Davidson on 'Modest World Cup Benefit'
- Energous Wireless Power added to Russell 3000 and 2000 indexes
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
